Piper Sandler Maintains Overweight on Erasca, Raises Price Target to $18

Benzinga Newsdesk www.benzinga.com Positive 60.3%

Neg 0% Neu 0% Pos 60.3%

Piper Sandler analyst Kelsey Goodwin maintains Erasca (NASDAQ:ERAS) with a Overweight and raises the price target from $11 to $18.